MX2022002774A - Método de captura y purificación de productos biológicos. - Google Patents
Método de captura y purificación de productos biológicos.Info
- Publication number
- MX2022002774A MX2022002774A MX2022002774A MX2022002774A MX2022002774A MX 2022002774 A MX2022002774 A MX 2022002774A MX 2022002774 A MX2022002774 A MX 2022002774A MX 2022002774 A MX2022002774 A MX 2022002774A MX 2022002774 A MX2022002774 A MX 2022002774A
- Authority
- MX
- Mexico
- Prior art keywords
- biologics
- capturing
- purification
- methods
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/58—Reaction vessels connected in series or in parallel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
- C12M37/02—Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0102—Alpha-glucosidase (3.2.1.20)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen métodos para la producción continua, captura y purificación de productos biológicos tales como proteínas recombinantes. También se describen composiciones farmacéuticas que comprenden dichos productos biológicos, así como métodos de tratamiento y usos de dichos productos biológicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962897018P | 2019-09-06 | 2019-09-06 | |
PCT/US2020/049535 WO2021046443A1 (en) | 2019-09-06 | 2020-09-04 | Method for capturing and purification of biologics |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022002774A true MX2022002774A (es) | 2022-06-14 |
Family
ID=72562004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022002774A MX2022002774A (es) | 2019-09-06 | 2020-09-04 | Método de captura y purificación de productos biológicos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230220320A1 (es) |
EP (1) | EP4025242A1 (es) |
JP (1) | JP2022546587A (es) |
KR (1) | KR20220058587A (es) |
CN (1) | CN114341333A (es) |
AU (1) | AU2020343680A1 (es) |
BR (1) | BR112022004000A2 (es) |
CA (1) | CA3149955A1 (es) |
MX (1) | MX2022002774A (es) |
WO (1) | WO2021046443A1 (es) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
US6244113B1 (en) | 1999-10-29 | 2001-06-12 | University Of Alabama In Huntsville | Method and apparatus for measuring microgravity acceleration |
EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
EP2649016B1 (en) * | 2010-12-06 | 2020-06-10 | Pall Corporation | Continuous processing methods for biological products |
SI3201320T1 (sl) | 2014-09-30 | 2024-02-29 | Amicus Therapeutics, Inc. | Zelo močna kislinska alfa-glukozidaza z okrepljenimi ogljikovimi hidrati |
KR20230041833A (ko) | 2015-12-30 | 2023-03-24 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 폼페병 치료용의 강화된 산 알파-글루코시다제 |
US10512676B2 (en) | 2016-03-30 | 2019-12-24 | Amicus Therapeutics, Inc. | Formulations comprising recombinant acid alpha-glucosidase |
KR20220145918A (ko) * | 2016-03-30 | 2022-10-31 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 고 m6p 재조합 단백질의 선택 방법 |
WO2020163480A1 (en) * | 2019-02-05 | 2020-08-13 | Amicus Therapeutics, Inc. | Recombinant human acid alpha-glucosidase and uses thereof |
-
2020
- 2020-09-04 EP EP20775526.5A patent/EP4025242A1/en active Pending
- 2020-09-04 MX MX2022002774A patent/MX2022002774A/es unknown
- 2020-09-04 CA CA3149955A patent/CA3149955A1/en active Pending
- 2020-09-04 WO PCT/US2020/049535 patent/WO2021046443A1/en unknown
- 2020-09-04 AU AU2020343680A patent/AU2020343680A1/en active Pending
- 2020-09-04 KR KR1020227010898A patent/KR20220058587A/ko unknown
- 2020-09-04 US US17/640,456 patent/US20230220320A1/en active Pending
- 2020-09-04 BR BR112022004000A patent/BR112022004000A2/pt not_active Application Discontinuation
- 2020-09-04 JP JP2022514655A patent/JP2022546587A/ja active Pending
- 2020-09-04 CN CN202080062893.6A patent/CN114341333A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230220320A1 (en) | 2023-07-13 |
CN114341333A (zh) | 2022-04-12 |
BR112022004000A2 (pt) | 2022-05-31 |
JP2022546587A (ja) | 2022-11-04 |
WO2021046443A1 (en) | 2021-03-11 |
AU2020343680A1 (en) | 2022-03-24 |
EP4025242A1 (en) | 2022-07-13 |
KR20220058587A (ko) | 2022-05-09 |
CA3149955A1 (en) | 2021-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500396A1 (en) | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof | |
MX2020006117A (es) | Integracion dirigida de acidos nucleicos. | |
MX2021014007A (es) | Proteinas de union a epcam y metodos de uso. | |
MX2022014533A (es) | Metodo para seleccionar proteinas recombinantes ricas en m6p. | |
MX2021001186A (es) | Purinonas como inhibidores de proteasa especifica de ubiquitina 1. | |
MX2021014286A (es) | Proteinas multiespecificas. | |
MX2018011162A (es) | Metodos de purificacion de colageno 7. | |
PH12018500379A1 (en) | Biopharmaceutical compositions | |
MX2013000958A (es) | Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma. | |
MX2023014077A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
EP4219540A3 (en) | Ctla-4 variant immunomodulatory proteins and uses thereof | |
MX2021000322A (es) | Enzimas de variante fosfopentomutasa modificada geneticamente. | |
MX2021001129A (es) | Metodo de purificacion de antigenos. | |
PH12020550927A1 (en) | Therapeutic enzyme fusion protein having novel structure and use thereof | |
PH12020500054A1 (en) | Novel therapeutic enzyme fusion protein and use thereof | |
ECSP20083339A (es) | Proteínas inmunodominantes y fragmentos en esclerosis múltiple | |
WO2017123610A3 (en) | Bacteria engineered to detoxify deleterious molecules | |
MX2018000023A (es) | Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina. | |
MX2022002437A (es) | Metodos para la produccion de arginasa humana recombinante 1 y sus usos. | |
PH12020551618A1 (en) | Erenumab compositions and uses thereof | |
MX2018009676A (es) | Proceso. | |
MX2022000742A (es) | Metodo para disminuir los efectos adversos del interferon. | |
MX2022002774A (es) | Método de captura y purificación de productos biológicos. | |
IL284402A (en) | A process for the production, isolation and purification of modified recombinant proteins | |
AU2014232502A8 (en) | Process for the preparation of 4-amino-1-((1S,4R, 5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one |